Tachycardia mediated cardiomyopathy: Pathophysiology, mechanisms, clinical features and management

International Journal of Cardiology

Volumn 172, Issue 1, 2014, Pages 40-46

  Gupta, Shuchita ^a   Figueredo, Vincent M ^a,b  

^a Einstein Heart and Vascular Center   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Tachyarrhythmias; Tachycardia mediated cardiomyopathy; Tachycardia induced heart failure

Indexed keywords

ANIMAL; CARDIOMYOPATHY, DILATED; COMPLICATION; HEART FAILURE; HUMAN; PATHOPHYSIOLOGY; TACHYCARDIA, SUPRAVENTRICULAR; TACHYCARDIA, VENTRICULAR;

ANIMALS; CARDIOMYOPATHY, DILATED; HEART FAILURE; HUMANS; TACHYCARDIA, SUPRAVENTRICULAR; TACHYCARDIA, VENTRICULAR;

EID: 84894048836     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2013.12.180     Document Type: Review

References (100)

1. A.M. Gossage, and J.A. Braxton Hicks On auricular fibrillation QJM 6 1913 435 440
2. E. Phillips, and S.A. Levine Auricular fibrillation without other evidence of heart disease: a cause of reversible heart failure Am J Med 7 1949 478 489
3. G.H. Whipple, L.T. Sheffield, and E.G. Woodman Reversible congestive heart failure due to chronic rapid stimulation of the normal heart Proc N Engl Cardiovasc Soc 20 1962 39 40
4. G. Fenelon, E. Wijns Andries, and P. Brugada Tachycardiomyopathy. Mechanisms and clinical implications Pacing Clin Electrophysiol 16 1996 95 106
5. F.G. Spinale, D.A. Hendrick, F.A. Crawford, A.C. Smith, Y. Hamada, and B.A. Carabello Chronic supraventricular tachycardia causes ventricular dysfunction and subendocardial injury in swine Am J Physiol 259 1990 218 229
6. E. Chow, J.C. Woodard, and D.J. Farrar Rapid ventricular pacing in pigs: an experimental model of congestive heart failure Am J Physiol 258 1990 1603 1605
7. J.S. Shinbane, M.A. Wood, and M. Jensen et al. Tachycardia-induced cardiomyopathy: a review of animal models and clinical studies J Am Coll Cardiol 29 1997 709 715
8. J.L. Zellner, F.G. Spinale, and D.M. Eble et al. Alterations in myocyte shape and basement membrane attachment with tachycardia-induced heart failure Circ Res 69 1991 590 600
9. J. Kajstura, X. Zhang, and Y. Liu et al. The cellular basis of pacing-induced dilated cardiomyopathy. Myocyte cell loss and myocyte cellular reactive hypertrophy Circulation 92 8 1995 2306 2317
10. R. Balijepalli, A.J. Lokuta, and N.A. Maertz et al. Depletion of T-tubules and specific subcellular changes in sarcolemmal proteins in tachycardia-induced heart failure Cardiovasc Res 59 1 2003 67 77
11. G.A. Langer Heart: excitation-contraction coupling Annu Rev Physiol 35 1973 55 86
12. D.E. Selby, B.M. Palmer, M.M. LeWinter, and M. Meyer Tachycardia-induced diastolic dysfunction and resting tone in myocardium from patients with a normal ejection fraction J Am Coll Cardiol 58 2 2011 147 154
13. G.W. Moe, C. Montgomery, and R.J. Howard et al. Left ventricular myocardial blood flow, metabolism and effects of treatment with enalapril: further insights into the mechanisms of canine experimental pacing-induced heart failure J Lab Clin Med 131 1993 294 302
14. F.G. Spinale, C. Clayton, and R. Tanaka et al. Myocardial Na, K-ATPase in tachycardia induced cardiomyopathy J Mol Cell Cardiol 24 1992 277 289
15. P.J. O'Brien, C.D. Ianuzzo, and G.W. Moe et al. Rapid ventricular pacing of dogs to heart failure: biochemical and physiological studies Can J Physiol Pharmacol 68 1990 34 45
16. J. Marin-Garcia, M.J. Goldenthal, and G.W. Moe Selective endothelin receptor blockade reverses mitochondrial dysfunction in canine heart failure J Card Fail 8 5 2002 326 332
17. G.W. Moe, and P. Armstrong Pacing-induced heart failure: a model to study the mechanism of disease progression and novel therapy in heart failure Cardiovasc Res 42 3 1999 591 599
18. F.G. Spinale, R. Tanaka, F.A. Crawford, and M.R. Zile Changes in myocardial blood flow during development of and recovery from tachycardia-induced cardiomyopathy Circulation 85 1992 717 729
19. R.P. Shannon, K. Komamura, and Y.T. Shen et al. Impaired regional subendocardial coronary flow reserve in conscious dogs with pacing-induced heart failure Am J Physiol 265 3.2 1993 801 809
20. M.J. Mihm, C. Coyle, and B.L. Schanbacher et al. Peroxynitrite induced nitration and inactivation of myofibrillar creatine kinase in experimental heart failure Cardiovasc Res 49 2001 798 807
21. M.J. Mihm, F. Yu, and C.A. Carnes et al. Impaired myofibrillar energetics and oxidative injury during human atrial fibrillation Circulation 104 2 2001 174 180
22. J. Shite, F. Qin, and W. Mao et al. Antioxidant vitamins attenuate oxidative stress and cardiac dysfunction in tachycardia-induced cardiomyopathy J Am Coll Cardiol 38 6 2001 1734 1740
23. H. Rigat, C. Hubert, and F. Alheno-Gelas et al. An insertion/deletion polymorphism in the angiotensin-I converting enzyme accounting for half the variance of serum enzyme levels J Clin Invest 86 1990 1343 1346
24. P.M. Deshmukh, R. Krishnamani, and M. Romanyshyn et al. Association of angiotensin converting enzyme gene polymorphism with tachycardia cardiomyopathy Int J Mol Med 13 3 2004 455 458
25. G.W. Moe, E.A. Grima, N.L. Wong, R.J. Howard, and P.W. Armstrong Dual natriuretic peptide system in experimental heart failure J Am Coll Cardiol 22 3 1993 891 898
26. G.W. Moe, C. Angus, R.J. Howard, A.J. De Bold, and P.W. Armstrong Pathophysiological role of changing atrial size and pressure in modulation of atrial natriuretic factor during evolving experimental heart failure Cardiovasc Res 24 7 1990 570 577
27. M.J. Fullerton, and J.W. Funder Aldosterone and cardiac fibrosis: in vitro studies Cardiovasc Res 28 1994 1863 1867
28. M.J. Young, E.Y. Lam, and A.J. Rickard Mineralocorticoid receptor activation and cardiac fibrosis Clin Sci (Lond) 112 9 2007 467 475
29. S.A. Burchell, F.G. Spinale, and F.A. Crawford et al. Effects of chronic tachycardia-induced cardiomyopathy on the beta-adrenergic receptor system J Thorac Cardiovasc Surg 104 4 1992 1006 1012
30. R. Tanaka, B.M. Fulbright, and R. Mukherjee et al. The cellular basis for the blunted response to beta-adrenergic stimulation in supraventricular tachycardia-induced cardiomyopathy J Mol Cell Cardiol 25 10 1993 1215 1233
31. F.G. Spinale, G.E. Tempel, and R. Mukherjee et al. Cellular and molecular alterations in the beta adrenergic system with cardiomyopathy induced by tachycardia Cardiovasc Res 28 8 1994 1243 1250
32. T.A. Timek, P. Dagum, and D.T. Lai et al. Pathogenesis of mitral regurgitation in tachycardia-induced cardiomyopathy Circulation 104 2001 I-47 I-53
33. T.A. Timek, P. Dagum, and D.T. Lai et al. Tachycardia-induced cardiomyopathy in the ovine heart: mitral annular dynamic three-dimensional geometry J Thorac Cardiovasc Surg 125 2 2003 315 324
34. T.A. Timek, D.T. Lai, and P. Dagum et al. Mitral leaflet remodeling in dilated cardiomyopathy Circulation 114 2006 I-518 I-523
35. Y.H. Jeong, K.J. Choi, and J.M. Song et al. Diagnostic approach and treatment strategy in tachycardia-induced cardiomyopathy Clin Cardiol 31 4 2008 172 178
36. W.S. McMahon, R. Mukherjee, and P.C. Gillette et al. Right and left ventricular geometry and myocyte contractile processes with dilated cardiomyopathy: myocyte growth and beta-adrenergic responsiveness Cardiovasc Res 31 2 1996 314 323
37. G. Dandamudi, A.Y. Rampurwala, and J. Mahenthiran et al. Persistent left ventricular dilatation in tachycardia-induced cardiomyopathy patients after appropriate treatment and normalization of ejection fraction Heart Rhythm 5 8 2008 1111 1114
38. M. Tomita, F.G. Spinale, F.A. Crawford, and M.R. Zile Changes in left ventricular volume, mass, and function during the development and regression of supraventricular tachycardia-induced cardiomyopathy. Disparity between recovery of systolic versus diastolic function Circulation 83 2 1991 635 644
39. L. Ling, J.M. Kalman, and A.H. Ellims et al. Diffuse ventricular fibrosis is a late outcome of tachycardia-mediated cardiomyopathy after successful ablation Circ Arrhythm Electrophysiol 6 2013 697 704
40. R.A. Grimm, W.J. Stewart, and K. Arheart et al. Left atrial appendage "stunning" after electrical cardioversion of atrial flutter: an attenuated response compared with atrial fibrillation as the mechanism for lower susceptibility to thromboembolic events J Am Coll Cardiol 29 1997 582 589
41. P. Sanders, J.B. Morton, and P.M. Kistler et al. Reversal of atrial mechanical dysfunction after cardioversion of atrial fibrillation: implications for the mechanisms of tachycardia-mediated atrial cardiomyopathy Circulation 108 2003 1976 1984
42. B.D. Hoit, Y. Takeishi, and M.J. Cox et al. Remodeling of the left atrium in pacing-induced atrial cardiomyopathy Mol Cell Biochem 238 1-2 2002 145 150
43. H. Sun, R. Gaspo, N. Leblanc, and S. Nattel Cellular mechanisms of atrial contractile dysfunction caused by sustained atrial tachycardia Circulation 98 7 1998 719 727
44. U. Schotten, J. Ausma, and C. Stellbrink et al. Cellular mechanisms of depressed atrial contractility in patients with chronic atrial fibrillation Circulation 103 2001 691 698
45. R. Wakili, Y. Yeh, and X. Yan Qi et al. Multiple potential molecular contributors to atrial hypocontractility caused by atrial tachycardia remodeling in dogs Circ Arrhythm Electrophysiol 3 2010 530 541
46. J.Q. Zhong, W. Zhang, and Y. Li et al. Changes in metalloproteinase and tissue inhibitor of metalloproteinase during tachycardia-induced cardiomyopathy by rapid atrial pacing in dogs Cardiology 106 1 2006 22 28
47. U. Schotten, M. Greiser, and D. Benke et al. Atrial fibrillation-induced atrial contractile dysfunction: a tachycardiomyopathy of a different sort Cardiovasc Res 53 2002 192 201
48. Z. Donghua, P. Jian, and X. Zhongbo et al. Reversal of cardiomyopathy in patients with congestive heart failure secondary to tachycardia J Interv Card Electrophysiol 36 2013 27 32
49. C. Medi, J.M. Kalman, and H. Haqqani et al. Tachycardia-mediated cardiomyopathy secondary to focal atrial tachycardia: long-term outcome after catheter ablation J Am Coll Cardiol 53 19 2009 1791 1797
50. D.M. Clark, V.J. Plumb, A.E. Epstein, and G.N. Kay Hemodynamic effects of an irregular sequence of ventricular cycle lengths during atrial fibrillation J Am Coll Cardiol 30 4 1997 1039 1045
51. A.M. Nia, N. Gassanov, and K.M. Dahlem et al. Diagnostic accuracy of NT-proBNP ratio (BNP-R) for early diagnosis of tachycardia-mediated cardiomyopathy: a pilot study Clin Res Cardiol 100 10 2011 887 896
52. P. Nerheim, S. Birger-Botkin, L. Piracha, and B. Olshanky Heart failure and sudden death in patients with tachycardia-induced cardiomyopathy and recurrent tachycardia Circulation 110 2004 247 252
53. A.S. Go, E.M. Hylek, and K.A. Phillips et al. Prevalence of diagnosed atrial fibrillation in adults. National implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors In Atrial Fibrillation (ATRIA) study JAMA 285 2001 2370e5
54. M. Naito, D. David, and E.L. Michelson et al. The hemodynamic consequences of cardiac arrhythmias: evaluation of the relative roles of abnormal atrioventricular sequencing, irregularity of ventricular rhythm and atrial fibrillation in a canine model Am Heart J 106 1983 284e91
55. D.G. Wyse, A.L. Waldo, and J.P. DiMarco et al. A comparison of rate control and rhythm control in patients with atrial fibrillation N Engl J Med 347 23 2002 1825 1833
56. I.C. Van Gelder, V.E. Hagens, and H.A. Bosker et al. A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation N Engl J Med 347 2002 1834 1840
57. S.D. Corley, A.E. Epstein, and J.P. DiMarco et al. Relationships between sinus rhythm, treatment, and survival in the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) study Circulation 109 2004 1509 1513
58. O.D. Pederson, H. Bagger, and N. Keller et al. Efficacy of dofetilide in the treatment of atrial fibrillation-flutter in patients with reduced left ventricular function Circulation 104 2001 292 296
59. G. Lee, P. Sanders, and J.M. Kalman Catheter ablation of atrial arrhythmias: state of the art Lancet 380 9852 2012 1509 1519
60. P.J. Gentlesk, W.H. Sauer, and E.P. Gerstenfeld et al. Reversal of left ventricular dysfunction following ablation of atrial fibrillation J Cardiovasc Electrophysiol 18 1 2007 9 14
61. M.N. Khan, P. Jaïs, and J. Cummings et al. Pulmonary-vein isolation for atrial fibrillation in patients with heart failure N Engl J Med 359 2008 1778 1785
62. D.G. Jones, S.K. Haldar, and W. Hussain et al. A randomized trial to assess catheter ablation versus rate control in the management of persistent atrial fibrillation in heart failure (ARC-HF) J Am Coll Cardiol 61 18 2013 1894 1903
63. C. Ozcan, A. Jahangir, and P.A. Friedman et al. Significant effects of atrioventricular node ablation and pacemaker implantation on left ventricular function and long-term survival in patients with atrial fibrillation and left ventricular dysfunction Am J Cardiol 92 1 2003 33 37
64. M. Gasparini, and P. Galimberti AV junction ablation in heart failure patients with atrial fibrillation treated with cardiac resynchronization therapy: the picture is now clear! J Am Coll Cardiol 59 8 2012 727 729
65. J. Luchsinger, and J. Steinberg Resolution of cardiomyopathy after ablation of atrial flutter J Am Coll Cardiol 32 1 1998 205 210
66. S. Pizzale, R. Lemery, and M.S. Green et al. Frequency and predictors of tachycardia-induced cardiomyopathy in patients with persistent atrial flutter Can J Cardiol 25 8 2009 469 472
67. F.E. Cruz, E.C. Cheriex, and J.L. Smeets et al. Reversibility of tachycardia induced cardiomyopathy after cure of incessant supraventricular tachycardia J Am Coll Cardiol 16 1990 739 744
68. F. Gaita, M. Haissaguerre, and C. Giustetto et al. Catheter ablation of permanent junctional reciprocating tachycardia with radiofrequency current J Am Coll Cardiol 25 3 1995 648 654
69. P.C. Dorostkar, M.J. Silka, F. Morady, and M. Dick II Clinical course of persistent junctional reciprocating tachycardia J Am Coll Cardiol 33 2 1999 366 375
70. J.V. Giovanni, A. Dindar, and M.J. Griffith et al. Recovery pattern of left ventricular dysfunction following radiofrequency ablation of incessant supraventricular tachycardia in infants and children Heart 79 1998 588 592
71. C. Sanchez, F. Benito, and F. Moreno et al. Reversibility of tachycardia-induced cardiomyopathy after radiofrequency ablation of incessant supraventricular tachycardia in infants Br Heart J 74 1995 332 333
72. N. Badhwar, and M.M. Scheinman Idiopathic ventricular tachycardia: diagnosis and management Curr Probl Cardiol 32 2007 7 43
73. J. Vijgen, P. Hill, L.A. Biblo, and M.D. Carlson Tachycardia-induced cardiomyopathy secondary to right ventricular outflow tract ventricular tachycardia: improvement of left ventricular systolic function after radiofrequency catheter ablation of the arrhythmia J Cardiovasc Electrophysiol 8 4 1997 445 450
74. W. Grimm, V. Menz, J. Hoffmann, and B. Maisch Reversal of tachycardia induced cardiomyopathy following ablation of repetitive monomorphic right ventricular outflow tract tachycardia Pacing Clin Electrophysiol 24 2 2001 166 171
75. J. Castro-Rodriguez, T. Verbeet, and M. Morissens et al. Complicated forms of tachycardia-mediated cardiomyopathy associated with idiopathic left ventricular tachycardia Pacing Clin Electrophysiol 34 2011 e52 e55
76. C. Hasdemir, C. Ulucan, and O. Yavuzgil et al. Tachycardia-induced cardiomyopathy in patientswith idiopathic ventricular arrhythmias: the incidence, clinical and electrophysiologic characteristics, and the predictors J Cardiovasc Electrophysiol 22 2011 663 668
77. C. Hasdemir, A. Yuksel, and D. Camli et al. Late gadolinium enhancement CMR in patients with tachycardia-induced cardiomyopathy caused by idiopathic ventricular arrhythmias Pacing Clin Electrophysiol 35 2012 465 470
78. G.A. Ng Treating patients with ventricular ectopic beats Heart 92 2006 1707 1712
79. S.K. Agarwal, R.J. Simpson Jr., and P. Rautaharju et al. Relation of ventricular premature complexes to heart failure (from the Atherosclerosis Risk In Communities [ARIC] study) Am J Cardiol 109 1 2012 105 109
80. D.F. Duffee, W.K. Shen, and H.C. Smith Suppression of frequent premature ventricular contractions and improvement of left ventricular function in patients with presumed idiopathic dilated cardiomyopathy Mayo Clin Proc 73 1998 430 433
81. Y. Kanei, M. Friedman, and N. Ogawa et al. Frequent premature ventricular complexes originating from the right ventricular outflow tract are associated with left ventricular dysfunction Ann Noninvasive Electrocardiol 13 2008 81 85
82. S. Niwano, Y. Wakisaka, and H. Niwano et al. Prognostic significance of frequent premature ventricular contractions originating from the ventricular outflow tract in patients with normal left ventricular function Heart 95 2009 1230 1237
83. T.S. Baman, D.C. Lange, and K.J. Ilg et al. Relationship between burden of premature ventricular complexes and left ventricular function Heart Rhythm 7 2010 865 869
84. J.F. Huizar, K. Kaszala, and J. Potfay et al. Left ventricular systolic dysfunction induced by ventricular ectopy: a novel model for premature ventricular contraction-induced cardiomyopathy Circ Arrhythm Electrophysiol 4 2011 543 549
85. D.D. Spragg, and D.A. Kass Pathobiology of left ventricular dyssynchrony and resynchronization Prog Cardiovasc Dis 49 2006 26 41
86. M. Yokokawa, H.M. Kim, and E. Good et al. Impact of QRS duration of frequent premature ventricular complexes on the development of cardiomyopathy Heart Rhythm 9 2012 1460 1464
87. H. Olgun, M. Yokokawa, and T. Baman et al. The role of interpolation in PVC-induced cardiomyopathy Heart Rhythm 8 7 2011 1046 1049
88. J. Ban, H. Park, and J. Park et al. Electrocardiographic and electrophysiological characteristics of premature ventricular complexes associated with left ventricular dysfunction in patients without structural heart disease Europace 15 5 2013 735 741
89. F. Del Carpio Munoz, F.F. Syed, and A. Noheria et al. Characteristics of premature ventricular complexes as correlates of reduced left ventricular systolic function: study of the burden, duration, coupling interval, morphology and site of origin of PVCs J Cardiovasc Electrophysiol 22 7 2011 791 798
90. R. Krittayaphong, K. Bhuripanyo, and K. Punlee et al. Effect of atenolol on symptomatic ventricular arrhythmia without structural heart disease: a randomized placebo-controlled study Am Heart J 144 2002 e10
91. S.N. Singh, R.D. Fletcher, and S.G. Fisher et al. Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure N Engl J Med 333 1995 77 82
92. C. Torp-Pedersen, M. Moller, and P.E. Bloch-Thomsen et al. Dofetilide in patients with congestive heart failure and left ventricular dysfunction. Danish Investigations of Arrhythmia and Mortality on Dofetilide Study Group N Engl J Med 341 1999 857 865
93. R.K. Yarlagadda, S. Iwai, and K.M. Stein et al. Reversal of cardiomyopathy in patients with repetitive monomorphic ventricular ectopy originating from the right ventricular outflow tract Circulation 112 2005 1092 1097
94. F. Bogun, T. Crawford, and S. Reich et al. Radiofrequency ablation of frequent, idiopathic premature ventricular complexes: comparison with a control group without intervention Heart Rhythm 4 2007 863 867
95. J.M. Taieb, P. Maury, and D. Shah et al. Reversal of dilated cardiomyopathy by the elimination of frequent left or right premature ventricular contractions J Interv Card Electrophysiol 20 2007 9 13
96. A.P. Wijnmaalen, V. Delgado, and M.J. Schalij et al. Beneficial effects of catheter ablation on left ventricular and right ventricular function in patients with frequent premature ventricular contractions and preserved ejection fraction Heart 96 2010 1275 1280
97. Y. Sekiguchi, K. Aonuma, and Y. Yamauchi et al. Chronic hemodynamic effects after radiofrequency catheter ablation of frequent monomorphic ventricular premature beats J Cardiovasc Electrophysiol 16 2005 1057 1106
98. C. HasdemIr, Y. Kartal, and E. SImsek et al. Time course of recovery of left ventricular systolic dysfunction in patients with premature ventricular contraction-induced cardiomyopathy Pacing Clin Electrophysiol 36 5 2013 612 617
99. P. Dahl, S. Danzi, and I. Klein Thyrotoxic cardiac disease Curr Heart Fail Rep 5 3 2008 170 176
100. C.W. Siu, C.Y. Yeung, and C.P. Lau et al. Incidence, clinical characteristics and outcome of congestive heart failure as the initial presentation in patients with primary hyperthyroidism Heart 93 4 2007 483 487